Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Jenna Demedis

TitleAsst Professor
InstitutionUniversity of Colorado Denver - Anschutz Medical Campus
DepartmentSOM-PEDS

    Collapse Biography 
    Collapse education and training
    University of California, Los Angeles, Los Angeles, CAB.S.06/2008Psychobiology
    Vanderbilt University School of Medicine, Nashville, TNM.D.05/2012Medicine
    University of Colorado School of Medicine, Aurora, CO06/2015Pediatrics (Residency)
    University of Colorado School of Medicine, Aurora, CO06/2018Pediatric Hematology/Oncology/BMT (Fellowship)
    University of Colorado, Aurora, COM.S.05/2018Master of Science - Clinical Science
    Collapse awards and honors
    2018Consortium Young Investigator Travel Award, Pediatric Blood and Marrow Transplant
    2018 - 2019Tanabe-Bobrow Family Young Investigator Award Endowed Fund, Children's Hospital Colorado

    Collapse Overview 
    Collapse overview
    Dr. Jenna Demedis is an Assistant Professor in the Division of Hematology/Oncology/Bone Marrow Transplantation at the University of Colorado School of Medicine. Dr. Demedis’s clinical focus is on taking care of children, adolescents and young adults with pediatric solid tumors of all types, as well as caring for survivors of pediatric cancers. Dr. Demedis’s clinical research career focuses on improving pediatric oncology outcomes, late effects from cancer, and patient quality of life. She has a specific interest in adolescent and young adult survivorship and sexual health. Dr. Demedis utilizes observational study design, Dissemination and Implementation science methods, and qualitative/mixed methods in her research.

    Collapse Research 
    Collapse research activities and funding
         (Jenna Sopfe)Jul 1, 2017 - Jun 30, 2019
    Thrasher Research Fund
    Evaluation of Malglycemia in the Pediatric Hematopoietic Stem Cell Transplant Population
    Role: Principal Investigator

         (Jenna Sopfe)Jul 1, 2017 - Jun 30, 2018
    Cancer League of Colorado
    Evaluation of Malglycemia in the Pediatric Hematopoietic Stem Cell Transplant Population
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Demedis J, Reedy J, Chow EJ, Dorsey Holliman B, Peterson PN, Studts CR. Provider perspectives and recommendations on standardized sexual function screening intervention in adolescent/young adult oncology patients. Pediatr Blood Cancer. 2024 Apr; 71(4):e30872. PMID: 38233999.
      View in: PubMed
    2. De Castro GC, Slatnick LR, Shannon M, Zhao Z, Jackson K, Smith CM, Whitehurst D, Elliott C, Clark CC, Scott HF, Friedman DL, Demedis J, Esbenshade AJ. Impact of Time-to-Antibiotic Delivery in Pediatric Patients With Cancer Presenting With Febrile Neutropenia. JCO Oncol Pract. 2024 Feb; 20(2):228-238. PMID: 38127868.
      View in: PubMed
    3. Zhao Z, Patel PA, Slatnick L, Sitthi-Amorn A, Bielamowicz KJ, Nunez FA, Walsh AM, Hess J, Rossoff J, Elgarten C, Myers R, Saab R, Basbous M, Mccormick M, Aftandilian C, Richards R, Nessle CN, Tribble AC, Sheth Bhutada JK, Coven SL, Runco D, Wilkes J, Gurunathan A, Guinipero T, Belsky JA, Lee K, Wong V, Malhotra M, Armstrong A, Jerkins LP, Cross SJ, Fisher L, Stein MT, Wu NL, Yi T, Orgel E, Haeusler GM, Wolf J, Demedis JM, Miller TP, Esbenshade AJ. Prospective External Validation of the Esbenshade Vanderbilt Models Accurately Predicts Bloodstream Infection Risk in Febrile Non-Neutropenic Children With Cancer. J Clin Oncol. 2024 Mar 01; 42(7):832-841. PMID: 38060973.
      View in: PubMed
    4. Meier KM, Linton A, Baldes C, Demedis J, Cost NG. Peripubertal Presentation of Metastatic Testicular Mixed, Nonseminomatous Germ Cell Tumor. Urology. 2024 02; 184:e239-e242. PMID: 37956765.
      View in: PubMed
    5. Smolik S, Miller AL, Mong DA, Trenbeath Z, Miller KR, Cost C, Demedis J. Incidence and Risk Factors for Brown Adipose Tissue Uptake in PET Imaging in Pediatric Patients. J Pediatr Hematol Oncol. 2024 01 01; 46(1):e60-e64. PMID: 37910816.
      View in: PubMed
    6. Cherven BO, Demedis J, Frederick NN. Sexual Health in Adolescents and Young Adults With Cancer. J Clin Oncol. 2024 Feb 20; 42(6):717-724. PMID: 37856773.
      View in: PubMed
    7. Cherven B, Ivankova NV, Spencer JB, Fitzpatrick AM, Burns KC, Demedis J, Hoefgen HR, Mertens AC, Klosky JL. Examining decisional needs and contextual factors influencing fertility status assessment among young female survivors of childhood cancer: A sequential mixed methods study protocol. PLoS One. 2023; 18(6):e0286511. PMID: 37315007.
      View in: PubMed
    8. Cai CR, Cornelius S, Demedis J, Hagen AM, Abbey-Lambertz M, Armstrong GT, Oeffinger KC, Syrjala KL, Taylor SL, Yi JC, Chow EJ. Experiences of adult survivors of childhood cancer in a randomized cardiovascular health promotion trial: a qualitative report from the Childhood Cancer Survivor Study. J Cancer Surviv. 2024 Oct; 18(5):1665-1673. PMID: 37253902.
      View in: PubMed
    9. Meier KM, Demedis J, Edwards M, Cost NG. Vaginal Rhabdoid Tumor Presenting as Prenatal Lower Urinary Tract Obstruction and Vaginal Mass. Urology. 2023 07; 177:175-177. PMID: 36736915.
      View in: PubMed
    10. Demedis J, Scarbro S, Suresh K, Maloney K, Forlenza GP. Hyperglycemia and Other Glycemic Measures Throughout Therapy for Pediatric Acute Lymphoblastic Leukemia and Lymphoma. J Pediatr Hematol Oncol. 2023 03 01; 45(2):e154-e160. PMID: 36715999.
      View in: PubMed
    Demedis's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description

    Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)